{"id":"W4389836815","doi":"10.1007/s00520-023-08176-6","title":"Efbemalenograstim alfa, an Fc fusion protein, long-acting granulocyte-colony stimulating factor for reducing the risk of febrile neutropenia following chemotherapy: results of a phase III trial","year":2023,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Custom Security Industries (Canada)","funders":"","keywords":"Medicine; Febrile neutropenia; Placebo; Docetaxel; Neutropenia; Internal medicine; Chemotherapy; Clinical endpoint; Adverse effect; Incidence (geometry); Breast cancer; Surgery; Absolute neutrophil count; Randomized controlled trial; Gastroenterology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001816414,0.000911339,0.001307442,0.0001611227,0.0002517366,0.0006235163,0.0004968421,0.001098963,0.00220189],"category_scores_gemma":[0.001078683,0.0002208629,0.001094914,0.000224792,0.0004825555,0.0003855762,0.0001540747,0.00163106,0.000433036],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005005419,"about_ca_system_score_gemma":0.000848736,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004267461,"about_ca_topic_score_gemma":0.001457083,"domain_scores_codex":[0.9996051,0.0002393751,0.00002538293,0.0000427645,0.00003608953,0.00005127205],"domain_scores_gemma":[0.999391,0.0001574408,0.0001657131,0.00004617751,0.00004015087,0.0001995819],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8667494,0.01795699,0.003155816,0.001181039,0.001918659,0.0001567189,0.0001124599,0.0009491566,0.01858982,0.0001751982,0.002409735,0.08664497],"study_design_scores_gemma":[0.8076892,0.1761224,0.008899862,0.0001166941,0.001058869,0.0002289036,0.0000280467,0.0006990809,0.002399056,0.0001667967,0.002573099,0.00001806255],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9838817,0.0104641,0.0006173481,0.0008239738,0.0002144683,0.001655806,0.0007128125,0.00005696762,0.001572663],"genre_scores_gemma":[0.9864146,0.00609414,0.001082186,0.001046666,0.0002555833,0.001753748,0.00146037,0.0000164603,0.001876153],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00220189,"threshold_uncertainty_score":0.009606183,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04650877393839486,"score_gpt":0.3896005932456712,"score_spread":0.3430918193072763,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}